Effects of protein synthesis inhibitors on angiotensin-stimulated and angiotensin-inhibited fluid transport by rat jejunum in vivo. 1977

J E Bolton, and K A Munday, and B J Parsons

A study has been made of the effects of protein synthesis inhibitors on the responses of rat jejunum in vivo to intravenous infusions of angiotensin. Actinomycin D, an inhibitor of the transcription stage of protein synthesis, was without effect on the stimulation of fluid transport which follows the infusion of low doses of angiotensin. Cycloheximide, an inhibitor of the translation stage of protein synthesis, blocked the stimulatory response to angiotensin, but was without effect on the inhibitory response to high doses of the hormone. It is concluded that low (physiological) doses of angiotensin stimulate fluid transport by a mechanism involving protein synthesis at a stage later than transcription whereas high doses of the hormone inhibit fluid transport by a process which does not require protein synthesis.

UI MeSH Term Description Entries
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008297 Male Males
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

J E Bolton, and K A Munday, and B J Parsons
November 1969, The Journal of physiology,
J E Bolton, and K A Munday, and B J Parsons
December 1977, The Journal of physiology,
J E Bolton, and K A Munday, and B J Parsons
January 1979, The Journal of physiology,
J E Bolton, and K A Munday, and B J Parsons
November 1981, The Journal of endocrinology,
J E Bolton, and K A Munday, and B J Parsons
May 1976, The Journal of physiology,
J E Bolton, and K A Munday, and B J Parsons
January 1983, The American journal of physiology,
J E Bolton, and K A Munday, and B J Parsons
May 1978, British journal of pharmacology,
J E Bolton, and K A Munday, and B J Parsons
March 1976, The Journal of endocrinology,
J E Bolton, and K A Munday, and B J Parsons
November 1993, Acta physiologica Scandinavica,
J E Bolton, and K A Munday, and B J Parsons
April 1985, Acta physiologica Scandinavica,
Copied contents to your clipboard!